NCT03385382View on ClinicalTrials.gov

Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

June 27, 2017

Study Completion Date

June 27, 2017

Conditions
Diabetic Macular Edema
Interventions
DRUG

Dexamethasone intravitreal implant 0.7 mg

Intravitreal Implant of dexamethasone

DRUG

Ranibizumab Injection

Injection of ranibizumab

All Listed Sponsors
lead

G. d'Annunzio University

OTHER

NCT03385382 - Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter